-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Teva Pharmaceuticals recently announced that it will announce the results of a long-term analysis of the effectiveness and safety of Fremanezumab at the 71st Annual Meeting of the American Academy of Neurology ( AAN ) .
Teva Pharmaceuticals recently announced that it will announce the results of a long-term analysis of the effectiveness and safety of Fremanezumab at the 71st Annual Meeting of the American Academy of Neurology ( AAN ) .
Fremanezumab is a fully humanized monoclonal antibody directed against calcitonin gene-related peptide ( CGRP ) α and β
Original source: Original source: Original source:
http://#axzz5mwpWeWX8
http://#axzz5mwpWeWX8 http://#axzz5mwpWeWX8 http://#axzz5mwpWeWX8http://www .This article is Metz Medicine ( MedSci ) original finishing compiler, Reprinted with authorization ! This article is Metz Medicine ( This article is Metz Medicine (This article is Metz Medicine ( MedSci MedSciMedSci ) original finishing compiler, Reprinted with authorization ) original finishing compiler, reprinted with authorization) original finishing compiler, reprinted with authorization ! !!
in this message